Worcester aesthetic and dermatology firm Or-Genix Therapeutics has created a new position and hired 20-year corporate development executive Cristina Griffin.
Hopkinton startup drugmaker Spring Bank Pharmaceuticals opened Monday trading up more than 5% after the company said it submitted an application to the U.S. Food and Drug Administration for a new cancer treatment.Â
Illinois drugmaker AbbVie, with a bioresearch center in Worcester employing 900, is acquiring the Irish maker of Botox in a cash and stock deal worth $63 billion.Â
Boston Scientific has closed on the $465-million acquisition of a California biotech about a month after announcing the deal that bolster’s the Marlborough medical device giant’s pain management offerings.
Thanks to several decades of hard work and planning and the growth of life science business parks in Worcester, the biotech cluster in Central Massachusetts is becoming known on the world stage.